Recent Hospitals releases

Pre-dialysis blood pressure measurements misclassify hypertension in about 1/3 of hemodialysis patients

[PRESSWIRE] Parma  - 06 August, 2018 -- New NDT study [1] shows that `normal´ pre-dialysis blood pressure measurement is not reliable. “Without performing extended ambulatory BP recordings (44h - 48h) we approvingly accept an error rate of about 30% in the diagnosis of hypertension in dialysis patients, a highly vulnerable patient group with a dramatically elevated cardiovascular risk. This is why EURECA-m recommends ambulatory blood pressure monitoring as gold standard for the diagnosis for hypertension in hemodialysis patient."

Launch of the ADPKD Patient Routemap: an interactive new resource to help empower patients and families

[PRESSWIRE] Copenhagen, Denmark - 24 May, 2018 -- ERA-EDTA Congress 2018 sees the launch of the ADPKD Patient Route Map, an interactive resource designed to help educate and empower people affected by autosomal dominant polycystic kidney disease (ADPKD).

Marken Announces Plans To Add Nursing Services To Home-Based Trials

 [PRESSWIRE] RESEARCH TRIANGLE PARK, North Carolina, April 17, 2018 -- Marken announced today their plans to develop a global home-based nursing network to supplement Marken's existing Direct to/from Patient (DTP/DFP) services.

Egyptian Cancer Care Gets Boost With Elekta Radiation Treatment Technology

 [PRESSWIRE] CAIRO, April 6, 2018 -- Egypt has again chosen Elekta (EKTA-B.ST) to equip its Ministry of Health hospitals, including the National Cancer Institute (NCI) in Cairo.

Grünenthal Group Receives CE-Certification for Innovative Surgical Sealant

 [PRESSWIRE] AACHEN, Germany, January 19, 2018 -- Grünenthal announced today that Adhesys Medical GmbH, a wholly-owned subsidiary of the Grünenthal Group, has received CE-Certification for MAR-CUTIS (Flix®). Flix® is a topical skin adhesive for surgical use and the first product from Grünenthal's innovative pipeline of surgical sealants. Further products, especially for use inside the body, are under development (MAR-VIVO product family).

Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport

 [PRESSWIRE] SHENZHEN, China, Jan. 15, 2018 -- Mindray, a global medical equipment solution provider, announced the release of BeneVision N1 Patient Monitor.

Capio Acquires yet Another Hospital and Radiology Unit in Denmark

[PRESSWIRE] GÖTEBORG, Sweden, Oct. 16, 2017 -- Capio has acquired Viborg Privathospital and MR Scanner Aarhus in an asset deal. The clinic in the city of Viborg is primarily specialized in orthopedics and general surgery while the operations at MR Scanner Aarhus comprise radiological examinations. Net sales in 2017 are estimated to MDKK 36. The acquisition is complementary to Capio's existing opera­tions on Jutland and some synergies are expected with the units in Skørping and Aarhus. 

New Article Showcases an Effective Surveillance System for General Care Units Using Masimo Patient SafetyNet™

[PRESSWIRE] IRVINE, Calif. - 15 August, 2016 -- Masimo (NASDAQ:MASI) announced today that a new article published in The Joint Commission Journal on Quality and Patient Safety reports on the results of an expansion of the use of Masimo Patient SafetyNet™* to more than 200 general floor beds at Dartmouth-Hitchcock Medical Center (D-H) in Lebanon, New Hampshire.1 

Free WiFi for the NHS – How WiFi SPARK Has Made This Happen

[PRESSWIRE] LONDON - 27 January, 2016 -- Free WiFi. Two words that we all expect in the public domain. Even more so for healthcare sites. Jeremy Hunt, the health secretary, announced that free WiFi is to be provided in all NHS buildings in an effort to improve treatment and patient experience.

Bone Therapeutics Granted an Additional EUR 2 Million in Non-Dilutive Funding by the Walloon Region

[PRESSWIRE] BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, today announces it has been granted an additional EUR 2 million in non-dilutive funding1 to support its research programs.